ERBB2 and invasive breast carcinoma: We employed two developmentally distinct human breast cell lines for this study: 1) BT474 (HER2+ invasive breast cancer cells), and 2) 21MT-1 (stable patient-derived metastatic breast cancer cells isolated from the metastatic pleural effusion).